Leptin Reduces Ovariectomy-Induced Bone Loss in Rats
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Bone mineral density increases with fat body mass, and obesity has a protective effect against osteoporosis. However, the relationship between fat body mass and bone mineral density is only partially explained by a combination of hormonal and mechanical factors. Serum leptin levels are strongly and directly related to fat body mass. We report here the effects of leptin administration compared with estrogen therapy on ovariectomy-induced bone loss in rats. Leptin was effective at reducing trabecular bone loss, trabecular architectural changes, and periosteal bone formation. Interestingly, the combination of estrogen and leptin further decreased bone turnover compared with that in estrogen-treated ovariectomized rats. Leptin also significantly increased osteoprotegerin mRNA steady state levels and protein secretion and decreased RANK ligand mRNA levels in human marrow stromal cells in vitro. Our findings suggest that leptin could modulate bone remodeling in favor of a better bone balance in rats. This study is the first evidence that leptin therapy has a significant effect in preventing ovariectomy-induced bone loss, and this effect may at least in part be mediated by the osteoprotegerin/RANK ligand pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R., & Lechler, R. I. (1998) · Nature · doi:10.1038/29795 · Cited by 2,160
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077 · cited 3×
“Ducy et al. ( 23 ) have recently shown that leptindeficient (ob/ob) and leptin receptor-deficient (db/db) mice have increased bone mass despite hypogonadism and hypercortisolism.”
BackgroundInfluential
Cited by
Control of osteoblast function and regulation of bone mass
Harada, S.-I., & Rodan, G. A. (2003) · Nature · doi:10.1038/nature01660 · Cited by 1,444
Mechanisms of Disease: is osteoporosis the obesity of bone?
Rosen, C. J., & Bouxsein, M. L. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0070 · Cited by 956
Effects of obesity on bone metabolism
Cao, J. J. (2011) · Journal of Orthopaedic Surgery and Research · doi:10.1186/1749-799x-6-30 · Cited by 765
Biological effects of conjugated linoleic acids in health and disease
Bhattacharya, A., Banu, J., Rahman, M., Causey, J., & Fernandes, G. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.02.009 · Cited by 662
Osteoporosis in Patients With Diabetes Mellitus
Hofbauer, L. C., Brueck, C. C., Singh, S. K., & Dobnig, H. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070510 · Cited by 503
Relationships between fat and bone
Reid, I. R. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0492-z · Cited by 475
Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo
Cornish, J., Callon, K., Bava, U., Lin, C., Naot, D., Hill, B., Grey, A., Broom, N., Myers, D., Nicholson, G., et al. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750405 · Cited by 472
“Those studies suggested that the effect was mediated by leptin-induced changes in mononuclear cell production of receptor activator of NF-B (RANK), and are complemented by the report of Burguera et al. (2001) that leptin increases osteoprotegerin levels and decreases RANK ligand levels in human marrow stromal cells.”
BackgroundInfluentialAdiponectin increases bone mass by suppressing osteoclast and activating osteoblast
Oshima, K., Nampei, A., Matsuda, M., Iwaki, M., Fukuhara, A., Hashimoto, J., Yoshikawa, H., & Shimomura, I. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.210 · Cited by 400
Chan, J. L., & Mantzoros, C. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66830-4 · Cited by 382
Antidiabetic effects of fermented soybean products on type 2 diabetes
Kwon, D. Y., Daily, J. W., Kim, H. J., & Park, S. (2010) · Nutrition Research · doi:10.1016/j.nutres.2009.11.004 · Cited by 368
Reid, I. R. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.06.027 · Cited by 367
Endocrine consequences of anorexia nervosa
Misra, M., & Klibanski, A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70180-3 · Cited by 341
Adiponectin as a novel determinant of bone mineral density and visceral fat
Lenchik, L., Register, T. C., Hsu, F.-C., Lohman, K., Nicklas, B. J., Freedman, B. I., Langefeld, C. D., Carr, J. J., & Bowden, D. W. (2003) · Bone · doi:10.1016/s8756-3282(03)00237-0 · Cited by 306
Thomas, T., Burguera, B., Melton, L. J., Atkinson, E. J., O’Fallon, W. M., Riggs, B. L., & Khosla, S. (2001) · Bone · doi:10.1016/s8756-3282(01)00487-2 · Cited by 282
Self-citationHamrick, M. W., Della-Fera, M. A., Choi, Y.-H., Pennington, C., Hartzell, D., & Baile, C. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050103 · Cited by 268
Peripheral leptin regulates bone formation
Turner, R. T., Kalra, S. P., Wong, C. P., Philbrick, K. A., Lindenmaier, L. B., Boghossian, S., & Iwaniec, U. T. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1734 · Cited by 264
Effects of Leptin on the Skeleton
Reid, I. R., Baldock, P. A., & Cornish, J. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00226 · Cited by 215
Oh, K. W., Lee, W. Y., Rhee, E. J., Baek, K. H., Yoon, K. H., Kang, M. I., Yun, E. J., Park, C. Y., Ihm, S. H., Choi, M. G., et al. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02312.x · Cited by 198
Pathogenesis of calciphylaxis: Hans Selye to nuclear factor κ-B
Weenig, R. H. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.12.006 · Cited by 183
Shah, K., Armamento-Villareal, R., Parimi, N., Chode, S., Sinacore, D. R., Hilton, T. N., Napoli, N., Qualls, C., & Villareal, D. T. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.475 · Cited by 173
Sienkiewicz, E., Magkos, F., Aronis, K. N., Brinkoetter, M., Chamberland, J. P., Chou, S., Arampatzi, K. M., Gao, C., Koniaris, A., & Mantzoros, C. S. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.016 · Cited by 166
Grethen, E., Hill, K. M., Jones, R., Cacucci, B. M., Gupta, C. E., Acton, A., Considine, R. V., & Peacock, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2280 · Cited by 136
“In ovariectomized rats, continuous sc leptin administration attenuated cancellous bone loss (25).”
BackgroundBariatric surgery, bone loss, obesity and possible mechanisms
Brzozowska, M. M., Sainsbury, A., Eisman, J. A., Baldock, P. A., & Center, J. R. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01050.x · Cited by 128
Martin, A., David, V., Malaval, L., Lafage-Proust, M.-H., Vico, L., & Thomas, T. (2007) · Endocrinology · doi:10.1210/en.2006-1541 · Cited by 111
“We confirmed previously published results using different models (10, 11, 27), because a low dose of leptin was able to prevent the disuse-induced decrease in BFR with significantly higher mineralizing surfaces, reflecting active osteoblast number.”
ResultSelf-citationPotential mechanisms linking psychological stress to bone health
Ng, J.-S., & Chin, K.-Y. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.50680 · Cited by 66
β-Adrenergic blockade and leptin replacement effectively mitigate disuse bone loss
Baek, K., & Bloomfield, S. A. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081241 · Cited by 53
Simha, V., Zerwekh, J. E., Sakhaee, K., & Garg, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020792 · Cited by 42
“However, it is not clear from the animal studies whether leptin is a stimulator or an inhibitor of bone growth, as intracerebroventricular infusion of leptin has been reported to reduce bone mass in both wild-type and leptin-deficient (ob/ob) mice (8), whereas systemic administration has been reported to increase bone…”
BackgroundVillareal, D. T. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2502 · Cited by 1
Metadata
- Authors
- Burguera, B.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2001-08-01
- Volume
- 142
- Issue
- 8
- Pages
- 3546-3553
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2171929497
- Cited by
- 316
- References
- 54
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.